.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

The OncLive Insider app is live!
CME Opportunities

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Management of Neurofibromatosis Type 1 with Plexiform Neurofibromas (NF1 with PNs)

EP. 1: Diagnosis of Neurofibromatosis Type 1

March 23rd 2020

EP. 2: Overview of Plexiform Neurofibromas in NF1

March 23rd 2020

EP. 3: Management of Plexiform Neurofibromas in NF1

March 23rd 2020

EP. 4: Disease Burden of NF1 with PNs

March 23rd 2020

EP. 5: Therapeutic Options for NF1 With PNs

March 23rd 2020

EP. 6: Managing Symptoms of NF1

March 23rd 2020

EP. 7: Treatment of NF1 With PNs: MEK Inhibition

March 23rd 2020

EP. 8: SPRINT Trial: NF1 With PNs

March 23rd 2020

EP. 9: NF1 With PNs: Future of Treatment With MEK Inhibitors

March 23rd 2020

EP. 10: Unmet Needs in the Management of NF1 With PNs

March 23rd 2020